These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 1272127)

  • 1. Letter: Methaqualone with psychotropic drugs: adverse interaction.
    Marriott PF
    Med J Aust; 1976 Mar; 1(12):412. PubMed ID: 1272127
    [No Abstract]   [Full Text] [Related]  

  • 2. Mandies are not dandy: another adverse drug interaction with methaqualone.
    Marriott P
    Compr Psychiatry; 1976; 17(6):779-80. PubMed ID: 991608
    [No Abstract]   [Full Text] [Related]  

  • 3. Methaqualone: efficacy as a hypnotic and side effects.
    Kessell A; Marriott PF; Graves DG
    Med J Aust; 1971 Mar; 1(10):531-4. PubMed ID: 5552458
    [No Abstract]   [Full Text] [Related]  

  • 4. [Deterrent and warning].
    Tidsskr Nor Laegeforen; 1971 Nov; 91(33):2427. PubMed ID: 5167210
    [No Abstract]   [Full Text] [Related]  

  • 5. Psychotropic--hypnotic drug combination.
    Kessell A; Williams AG
    Lancet; 1967 Sep; 2(7516):612. PubMed ID: 4166844
    [No Abstract]   [Full Text] [Related]  

  • 6. Letter: Adverse effect of methaqualone.
    Hoaken PC
    Can Med Assoc J; 1975 Mar; 112(6):685. PubMed ID: 1122439
    [No Abstract]   [Full Text] [Related]  

  • 7. Combined cannabis/methaqualone withdrawal treated with psychotropic analgesic nitrous oxide.
    Gillman MA; Harker N; Lichtigfeld FJ
    Int J Neurosci; 2006 Jul; 116(7):859-69. PubMed ID: 16861151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Mandrax": no significant side effects.
    Weston F
    Med J Aust; 1971 Aug; 2(8):446. PubMed ID: 5095711
    [No Abstract]   [Full Text] [Related]  

  • 9. [Methaqualone: toxic minor hypnotic of choice].
    Suttel R
    Clin Toxicol; 1975; 8(3):359-62. PubMed ID: 1175349
    [No Abstract]   [Full Text] [Related]  

  • 10. Letter: Metabolic drug interactions -- a pyschiatrist's viewpoint.
    Marriot P
    Med J Aust; 1975 Jul; 2(1):33. PubMed ID: 1160713
    [No Abstract]   [Full Text] [Related]  

  • 11. Methaqualone abuse patterns, diversion paths and adverse reactions.
    Inciardi JA; Petersen DM; Chambers CD
    JFMA; 1974 Apr; 61(4):279-83. PubMed ID: 4819628
    [No Abstract]   [Full Text] [Related]  

  • 12. Fixed drug eruption due to methaqualone.
    Slazinski L; Knox DW
    Arch Dermatol; 1984 Aug; 120(8):1073-5. PubMed ID: 6235782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [No more griseofulvin for pill users: another clinically important interaction?].
    Offerhaus L
    Ned Tijdschr Geneeskd; 1984 Aug; 128(33):1579-80. PubMed ID: 6483028
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug therapy reviews. Rational use of psychotropic drugs. I. Hypnotics.
    Greenblatt DJ; Miller RR
    J Maine Med Assoc; 1974 Aug; 65(8):192-7. PubMed ID: 4152843
    [No Abstract]   [Full Text] [Related]  

  • 15. Once daily administration of a fluphenazine/nortriptyline preparation in the treatment of mixed anxiety/depressive states.
    Brodie NH; McGhie RL; O'Hara H; O'Hara J; Rodway AE; Valle-Jones JC; Schiff AA
    Curr Med Res Opin; 1976; 4(5):346-52. PubMed ID: 795608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reproductive biology and psychotropic treatments in premenopausal women with bipolar disorder.
    Joffe H
    J Clin Psychiatry; 2007; 68 Suppl 9():10-5. PubMed ID: 17764379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Adverse effects of methaqualone].
    Med Klin; 1971 Aug; 66(23):1132. PubMed ID: 5561859
    [No Abstract]   [Full Text] [Related]  

  • 18. Examination of the potential interaction between ketoconazole (Nizoral) and oral contraceptives with special regard to products of low hormone content (Rigevidon, anteovin).
    Kovács I; Somos P; Hámori M
    Ther Hung; 1986; 34(3):167-70. PubMed ID: 3441880
    [No Abstract]   [Full Text] [Related]  

  • 19. [Influence of neuropharmaca on hormonal contraception].
    Hempel E; Klinger G
    Dtsch Gesundheitsw; 1976 Mar; 31(10):443-4. PubMed ID: 1278004
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of cytochrome P4502D6 activity with paroxetine normalizes the ultrarapid metabolizer phenotype as measured by nortriptyline pharmacokinetics and the debrisoquin test.
    Laine K; Tybring G; Härtter S; Andersson K; Svensson JO; Widén J; Bertilsson L
    Clin Pharmacol Ther; 2001 Oct; 70(4):327-35. PubMed ID: 11673748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.